Eastwood, M C, Busby, J, Jackson, D J, Pavord, I D, Hanratty, C E, Djukanovic, R, Woodcock, A, Walker, S, Hardman, T C, Arron, J R, Choy, D F, Bradding, P, Brightling, C E, Chaudhuri, R, Cowan, D, Mansur, A H, Fowler, S J, Howarth, P, Lordan, J, Menzies-Gow, A, Harrison, T, Robinson, D S, Holweg, C T J, Matthews, J G, Heaney, L G & RASPUK Investigators 2023, ' A randomized trial of a composite T2-biomarker strategy adjusting corticosteroid treatment in severe asthma: a post-hoc analysis by sex ', The Journal of Allergy and Clinical Immunology: In Practice, vol. 11, no. 4, pp. 1233-1242.e5 . https://doi.org/10.1016/j.jaip.2022.12.019 RASPUK Investigators 2023, ' A randomised trial of a T2-composite-biomarker strategy adjusting corticosteroidtreatment in severe asthma, a post-hoc analysis by sex ', The journal of allergy and clinical immunology. In practice . https://doi.org/10.1016/j.jaip.2022.12.019
Yang, F, Busby, J, Heaney, L G, Pavord, I, Brightling, C, Borg, K, McDowell, P J, Diver, S E, Shrimanker, R, Bradding, P, Shepherd, M & Chaudhuri, R 2022, ' Corticosteroid responsiveness following mepolizumab in severe eosinophilic asthma-a randomised, placebo-controlled crossover trial (MAPLE) ', The Journal of Allergy and Clinical Immunology: In Practice . https://doi.org/10.1016/j.jaip.2022.06.050